DUSP12
Dual specificity protein phosphatase 12
Also known as: DUS12_HUMAN, DUSP1, YVH1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UNI6
- Gene
- DUSP12
- Ensembl
- ENSG00000081721
- Chromosome
- 1
- Canonical length
- 340 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
The protein encoded by this gene is a member of the dual specificity protein phosphatase subfamily. These phosphatases inactivate their target kinases by dephosphorylating both the phosphoserine/threonine and phosphotyrosine residues. They negatively regulate members of the mitogen-activated protein (MAP) kinase superfamily (MAPK/ERK, SAPK/JNK, p38), which is associated with cellular proliferation and differentiation. Different members of the family of dual specificity phosphatases show distinct substrate specificities for various MAP kinases, different tissue distribution and subcellular localization, and different modes of inducibility of their expression by extracellular stimuli. This gene product is the human ortholog of the Saccharomyces cerevisiae YVH1 protein tyrosine phosphatase. It is localized predominantly in the nucleus, and is novel in that it contains, and is regulated by a zinc finger domain. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
340 residues, UniProt reviewed canonical sequence.
>Q9UNI6|DUSP12
1 MLEAPGPSDG CELSNPSASR VSCAGQMLEV QPGLYFGGAA AVAEPDHLRE AGITAVLTVD
61 SEEPSFKAGP GVEDLWRLFV PALDKPETDL LSHLDRCVAF IGQARAEGRA VLVHCHAGVS
121 RSVAIITAFL MKTDQLPFEK AYEKLQILKP EAKMNEGFEW QLKLYQAMGY EVDTSSAIYK
181 QYRLQKVTEK YPELQNLPQE LFAVDPTTVS QGLKDEVLYK CRKCRRSLFR SSSILDHREG
241 SGPIAFAHKR MTPSSMLTTG RQAQCTSYFI EPVQWMESAL LGVMDGQLLC PKCSAKLGSF
301 NWYGEQCSCG RWITPAFQIH KNRVDEMKIL PVLGSQTGKILocalizationUniProt · AlphaFold · HPA
Whether an antibody against DUSP12 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 29 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 29 nTPM
- cerebellum: 18 nTPM
- ovary: 14 nTPM
- breast: 13 nTPM
- endometrium: 13 nTPM
- lymph node: 13 nTPM
Single-cell type
- gastric progenitor cells: 36 nCPM
- tuft cells: 35 nCPM
- parietal cells: 32 nCPM
- esophageal basal cells: 31 nCPM
- extravillous trophoblasts: 31 nCPM
- granulosa cells: 29 nCPM
Immune cell
- basophil: 32 nTPM
- NK-cell: 29 nTPM
- MAIT T-cell: 23 nTPM
- myeloid DC: 22 nTPM
- naive CD8 T-cell: 22 nTPM
- memory CD4 T-cell: 21 nTPM
Brain region
- cerebellum: 9.8 nTPM
- white matter: 7.3 nTPM
- cerebral cortex: 6 nTPM
- hypothalamus: 6 nTPM
- basal ganglia: 5.8 nTPM
- spinal cord: 5.7 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about DUSP12.
Disease | ImmuneIEDB
Conditions an epitope on DUSP12 was assayed in.
- skin melanoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.89
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.58
- DepMap mean gene effect
- -0.22
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 13% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- kinase binding
- phosphatase activity
- protein serine/threonine phosphatase activity
- protein tyrosine phosphatase activity
- protein tyrosine/serine/threonine phosphatase activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DUSP12 as an antibody target. Whether an autoantibody or antibody against DUSP12 could matter depends on whether native DUSP12 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DUSP12 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DUSP12 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...